BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

621 related articles for article (PubMed ID: 32270417)

  • 1. Risk factors for breast cancer-related lymphedema: correlation with docetaxel administration.
    Aoishi Y; Oura S; Nishiguchi H; Hirai Y; Miyasaka M; Kawaji M; Shima A; Nishimura Y
    Breast Cancer; 2020 Sep; 27(5):929-937. PubMed ID: 32270417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The incidence and risk factors of related lymphedema for breast cancer survivors post-operation: a 2-year follow-up prospective cohort study.
    Zou L; Liu FH; Shen PP; Hu Y; Liu XQ; Xu YY; Pen QL; Wang B; Zhu YQ; Tian Y
    Breast Cancer; 2018 May; 25(3):309-314. PubMed ID: 29397555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of neoadjuvant chemotherapy on breast cancer-related lymphedema after axillary lymph node dissection: a retrospective cohort study.
    Jia M; Pan L; Yang H; Gao J; Guo F
    Breast Cancer Res Treat; 2024 Apr; 204(2):223-235. PubMed ID: 38097882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The incidence and risk factors for occurrence of arm lymphedema after treatment of breast cancer.
    Rebegea L; Firescu D; Dumitru M; Anghel R
    Chirurgia (Bucur); 2015; 110(1):33-7. PubMed ID: 25800313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors Associated With Lymphedema in Women With Node-Positive Breast Cancer Treated With Neoadjuvant Chemotherapy and Axillary Dissection.
    Armer JM; Ballman KV; McCall L; Ostby PL; Zagar E; Kuerer HM; Hunt KK; Boughey JC
    JAMA Surg; 2019 Sep; 154(9):800-809. PubMed ID: 31314062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obesity is a risk factor for developing postoperative lymphedema in breast cancer patients.
    Helyer LK; Varnic M; Le LW; Leong W; McCready D
    Breast J; 2010; 16(1):48-54. PubMed ID: 19889169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of axillary surgery and radiotherapeutic strategy on the risk of lymphedema and upper extremity dysfunction in early breast cancer patients.
    Zheng SY; Chen CY; Qi WX; Cai G; Xu C; Cai R; Qian XF; Shen KW; Cao L; Chen JY
    Breast; 2023 Apr; 68():142-148. PubMed ID: 36764019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Residual lymph node disease after neoadjuvant chemotherapy predicts an increased risk of lymphedema in node-positive breast cancer patients.
    Specht MC; Miller CL; Skolny MN; Jammallo LS; O'Toole J; Horick N; Isakoff SJ; Smith BL; Taghian AG
    Ann Surg Oncol; 2013 Sep; 20(9):2835-41. PubMed ID: 23689935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of the Axilla in T1-2 Breast Cancer Patients with Macrometastatic Sentinel Node Involvement Who Underwent Breast-Conserving Therapy.
    Kuru B; Yuruker S; Sullu Y; Gursel B; Ozen N
    J Invest Surg; 2019 Jan; 32(1):48-54. PubMed ID: 28945489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Lymphedema Surveillance Program for Breast Cancer Patients Reveals the Promise of Surgical Prevention.
    Hahamoff M; Gupta N; Munoz D; Lee BT; Clevenger P; Shaw C; Spiguel L; Singhal D
    J Surg Res; 2019 Dec; 244():604-611. PubMed ID: 29397949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantifying the Impact of Axillary Surgery and Nodal Irradiation on Breast Cancer-Related Lymphedema and Local Tumor Control: Long-Term Results From a Prospective Screening Trial.
    Naoum GE; Roberts S; Brunelle CL; Shui AM; Salama L; Daniell K; Gillespie T; Bucci L; Smith BL; Ho AY; Taghian AG
    J Clin Oncol; 2020 Oct; 38(29):3430-3438. PubMed ID: 32730184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time trend of breast cancer-related lymphedema according to body mass index.
    Ogiya A; Kimura K; Ueno T; Iwase T; Ohno S
    Eur J Surg Oncol; 2024 Jun; 50(6):108350. PubMed ID: 38653160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical application of axillary reverse mapping in patients with breast cancer: A systematic review and meta-analysis.
    Wijaya WA; Peng J; He Y; Chen J; Cen Y
    Breast; 2020 Oct; 53():189-200. PubMed ID: 32858404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of axillary reverse mapping related factors on lymphedema in breast cancer patients.
    Ikeda K; Ogawa Y; Kajino C; Deguchi S; Kurihara S; Tashima T; Goto W; Nishiguchi Y; Tokunaga S; Fukushima H; Inoue T
    Eur J Surg Oncol; 2014 Jul; 40(7):818-23. PubMed ID: 24768416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial].
    Sávolt A; Musonda P; Mátrai Z; Polgár C; Rényi-Vámos F; Rubovszky G; Kovács E; Sinkovics I; Udvarhelyi N; Török K; Kásler M; Péley G
    Orv Hetil; 2013 Dec; 154(49):1934-42. PubMed ID: 24292111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative analysis of the correlation between axillary treatment and upper limb lymphedema].
    Lin Y; Xu Y; Zhang XH; Wang CJ; Sun Q
    Zhonghua Wai Ke Za Zhi; 2019 Sep; 57(9):713-716. PubMed ID: 31474063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Impact of Radiation Therapy, Lymph Node Dissection, and Hormonal Therapy on Outcomes of Tissue Expander-Implant Exchange in Prosthetic Breast Reconstruction.
    Wang F; Peled AW; Chin R; Fowble B; Alvarado M; Ewing C; Esserman L; Foster R; Sbitany H
    Plast Reconstr Surg; 2016 Jan; 137(1):1-9. PubMed ID: 26368331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of combined risk factors on breast cancer-related lymphedema: a study using decision trees.
    Jinbo K; Fujita T; Kasahara R; Jinbo R; Kisara S; Onobe J; Kimijima I; Yasuda M; Yamamoto Y
    Breast Cancer; 2023 Jul; 30(4):685-688. PubMed ID: 36917351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Axillary evaluation and lymphedema in women with ductal carcinoma in situ.
    Coromilas EJ; Wright JD; Huang Y; Feldman S; Neugut AI; Hillyer GC; Chen L; Hershman DL
    Breast Cancer Res Treat; 2016 Jul; 158(2):373-84. PubMed ID: 27365080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of neoadjuvant chemotherapy on operative adverse events and chemotherapy and radiotherapy in patients undergoing immediate breast reconstruction.
    Adachi Y; Okumura S; Sawaki M; Hattori M; Yoshimura A; Gondo N; Kotani H; Iwase M; Kataoka A; Sugino K; Horisawa N; Ozaki Y; Endo Y; Sakamoto S; Iwata H
    Breast Cancer; 2020 Jul; 27(4):716-723. PubMed ID: 32162180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.